Reply to the Letter to the Editor Entitled “Prognostic Value of Elevated Pulmonary Artery Systolic Pressure on Short Term in Patients With Acute Myocardial Infarction”
Restricted accessLetterFirst published online February, 2021
Reply to the Letter to the Editor Entitled “Prognostic Value of Elevated Pulmonary Artery Systolic Pressure on Short Term in Patients With Acute Myocardial Infarction”
PamukcuHEAçikelS. Prognostic value of elevated pulmonary artery systolic pressure on short term in patients with acute myocardial infarction [published online July 17, 2020]. Angiology. 2020:3319720941723. doi:10.1177/0003319720941723
2.
FanXTWangSJMujahidHJiXP. Effect of elevated pulmonary artery systolic pressure on short-term prognosis in patients with acute myocardial infarction. Angiology. 2020;71:567–72.
3.
MutlakDLessickJCarassoS, et al.Utility of pulmonary hypertension for the prediction of heart failure following acute myocardial infarction. Am J Cardiol. 2012;109:1254–9.
4.
GalièNHumbertMVachieryJL, et al.2015 ESC/ERS Guidelines for the diagnosis and treatment of pulmonary hypertension: The Joint Task Force for the Diagnosis and Treatment of Pulmonary Hypertension of the European Society of Cardiology (ESC) and the European Respiratory Society (ERS): endorsed by: Association for European Paediatric and Congenital Cardiology (AEPC), International Society for Heart and Lung Transplantation (ISHLT). Eur Heart J. 2016;37:67–119.
5.
WuEOrtizJTTejedorP, et al.Infarct size by contrast enhanced cardiac magnetic resonance is a stronger predictor of outcomes than left ventricular ejection fraction or end-systolic volume index: prospective cohort study. Heart. 2008;94:730–6.
6.
LagerqvistBHustedSKontnyF, et al.; Fast Revascularisation during InStability in Coronary artery disease (FRISC-II) Investigators. 5-year outcomes in the FRISC-II randomised trial of an invasive versus a non-invasive strategy in non-ST-elevation acute coronary syndrome: a follow-up study. Lancet. 2006;368:998–1004.
7.
LevineGNBatesERBlankenshipJC, et al.2015 ACC/AHA/SCAI focused update on primary percutaneous coronary intervention for patients with ST-elevation myocardial infarction: an update of the 2011 ACCF/AHA/SCAI guideline for percutaneous coronary intervention and the 2013 ACCF/AHA guideline for the management of ST-elevation myocardial infarction: a report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines and the Society for Cardiovascular Angiography and Interventions [published correction appears in Circulation 2016;133:e442-3]. Circulation. 2016;133:1135–47.
8.
RoffifiMPatronoCColletJP, et al.2015 ESC Guidelines for the management of acute coronary syndromes in patients presenting without persistent ST-segment elevation: Task force for the management of acute coronary syndromes in patients presenting without persistent ST-segment elevation of the European Society of Cardiology (ESC). Eur Heart J. 2016;37:267–315.
